Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission
Clinical trial NCT02530125 · TERMINATED
Trial details
- NCT number
- NCT02530125
- Sponsor
- Northwestern University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-01-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.